In summary, these results demonstrate the crucial role of DEPP in regulating adipocyte programs and metabolism, providing new avenues for further understanding the transition between WAT and BAT and a novel potential target for the treatment of obesity and insulin resistance. This evidence concerns the gene DEPP1 and obesity due to melanocortin 4 receptor deficiency.